These findings are in line with our results, as we were not able to reveal any significant differences of the sFlt-1/PlGF ratio between women with chronic hypertension or a history of preeclampsia, as well as women with APS/SLE, thrombophilia, a pathologic first trimester screening for preeclampsia and controls. This evidence concerns the gene PGF and autoimmune polyendocrinopathy.